Author

R. Sherwood

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

P. Jagannathan· 3 shared S. Zhang· 3 shared T. T. Wang· 3 shared S. Bournazos· 2 shared A. Cassidy· 1 shared A. Gajewski· 1 shared A. Sinnott· 1 shared B. L. Sievers· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

P. Jagannathan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response

S. Chakraborty, J. C. Gonzalez, B. L. Sievers, V. Mallajosyula, M. Dubey, Y.-L. B. Cheng, K. Q. T. Tran, S. Chakraborty, A. Cassidy, S. T. Chen, A. Sinnott, T. Gelbart, Y. Golan, M. Prahl, U. Singh, , T. T. Wang

The paper identifies early antibody responses that predict COVID-19 severity and vaccine response, showing functional differences in inflammation regulation.

bioRxiv · May 25, 2021 · PreprintImmunology

FcRn, but not FcgRs, drives maternal-fetal transplacental transport of human IgGantibodies

S. Borghi, S. Bournazos, N. Thulin, C. Li, A. Gajewski, R. Sherwood, S. Zhang, E. Harris, P. Jagannathan, L.-X. Wang, J. V. Ravetch, T. T. Wang

This study shows that FcRn, not FcγRs, is responsible for maternal-fetal transport of IgG antibodies, suggesting FcRn engineering could improve antibody transfer to the fetus.

bioRxiv · Mar 22, 2020Immunology

Afucosylated maternal anti-dengue IgGs are a biomarker for susceptibility to dengue disease in their infants

N. K. Thulin, R. C. Brewer, R. Sherwood, S. Bournazos, K. G. Edwards, N. S. Ramadoss, J. K. Taubenberger, M. Memoli, P. Jagannathan, S. Zhang, D. H. Libraty, T. T. Wang

The paper identifies afucosylation of maternal anti-dengue IgGs as a biomarker for infant susceptibility to symptomatic dengue infections and explains its mechanism involving Fc{gamma}RIIIa-mediated enhancement of viral replication.

bioRxiv · Mar 6, 2019 · PreprintImmunology